Evidence map›Paper›PMID 34148947›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Novel Mutations of the ALMS1 Gene in Patients with Alström Syndrome.

Chunmei Wang, Xiaona Luo, Yilin Wang, Zhao Liu, Shengnan Wu, Simei Wang, Xiaoping Lan, Quanmei Xu, Wuhen Xu, Fang Yuan and 4 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Chunmei WangDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Xiaona LuoDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Yilin WangDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Zhao LiuDivision of Pediatric Neurology, Department of Pediatrics, University of Illinois and Children's Hospital of Illinois, USA.
Shengnan WuDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Simei WangDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Xiaoping LanDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Quanmei XuDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Wuhen XuDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Fang YuanDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Anqi WangDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Fanyi ZengNHC Key Laboratory of Medical Embryogenesis and Developmental Molecular Biology & Shanghai Key Laboratory of Embryo and Reproduction Engineering, China.
Jia JiaFuxiang Gene Engineering Research Institute, China.
Yucai ChenDepartment of Neurology, Children's Hospital of Shanghai, Shanghai JiaoTong University, China.
Shanghai Jiao Tong University · CNShanghai Children's Hospital · CNChildren's Hospital of Illinois · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Alström syndrome is an autosomal recessive genetic disease caused by a mutation in the ALMS1 gene. Alström syndrome is clinically characterized by multisystem involvement, including sensorineural deafness, cone-rod dystrophy, nystagmus, obesity, insulin resistance, type 2 diabetes and hypogonadism. The diagnosis is thus challenging for patients without this characteristic set of clinical symptoms. We explored the effectiveness of whole-exome sequencing in the diagnosis of Alström syndrome. Methods A girl with symptoms of Alström syndrome was tested and diagnosed with the disease by whole-exome sequencing. Results Whole-exome sequencing revealed two novel variants, c.6160_6161insAT: p.Lys2054Asnfs*21 (exon 8) and c.10823_10824 delAG:p.Glu 3608Alafs*9 (exon16) in the ALMS1 gene, leading to premature termination codons and the domain of ALMS1 protein. Blood sample testing of her asymptomatic parents revealed them to be heterozygous carriers of the same mutations. Assembly showed that the mutations on both alleles were located in conserved sequences. A review of the ALMS1 gene nonsense mutation status was performed. Conclusion We herein report two novel variants of the ALMS1 gene discovered in a Chinese Alström syndrome patient that expand the mutational spectrum of ALMS1 and provided new insight into the molecular mechanism underlying Alström syndrome. Our findings add to the current knowledge concerning the diagnosis and treatment of Alström syndrome.

Indexed as

Alstrom SyndromeCell Cycle ProteinsDiabetes Mellitus, Type 2FemaleHumansMutationPedigreeALMS1 protein, humanCell Cycle ProteinsALMS1Alström syndromemutationsnonsense mutation

Identifiers

PMID34148947
PMCPMC8710367
OpenAlexW3173314112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.